EGFR and non-small cell lung carcinoma: Mutations in the EGFR gene are prevalent in approximately ~15% of patients with NSCLC (~50% in Asians), and they play a primary role in disrupting cellular functions such as cell growth, survival, invasion, and angiogenesis.